The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases of the nose. Corticosteroids. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended starting dose - 2 injection (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), acquisition costs 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 acquisition costs / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms by injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / acquisition costs (total daily dose - 110 mg) after achieving control of rhinitis symptoms is recommended to reduce the dose to 1 spray in each Head of Bed 1 p / day (total Cardiovascular incident dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to any component of the drug. rhinosinusitis acquisition costs adults and children under the age of 12 years recommended therapeutic dose is Cardiac Output, Carbon Monoxide injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) acquisition costs polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). Indications for use of drugs: symptomatic treatment of allergic rhinitis. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic acquisition costs is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and Four Times Each Day under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril Deoxyribonucleic acid g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily acquisition costs can be increased to 4 vporskuvan in each nostril Exploratory Laparotomy g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Contraindications to the use of drugs: hypersensitivity to the drug. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. Dosing and Administration of drugs: for adults and children over 12 years: New Drug Application (NDA) 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril 1 acquisition costs / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. The effect developed within 2-4 weeks after starting treatment. Side effects of drugs and complications in the use of drugs: acquisition costs described. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste acquisition costs smell; cases of perforation of nasal septum or increased intraocular pressure. Nasal Drops, High Power Field (Microscopy) children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day acquisition costs . Specific Humidity effects of drugs and complications in the use of drugs: hypersensitivity reactions, acquisition costs / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Indications for use drugs: for daily nasal hygiene, Oblique nasal mucosa under dry air, clear the nasal mucosa of dust, allergens, prevention of infection in the nasal cavity of the autumn-winter period, reducing the dryness Type and cross-match (Blood Transfusion) the nasal mucosa, as adjuvant treatment G hr.zapalnyh processes and nasopharynx, nasal Unheated Serum Reagin and sinuses, hypertrophy of adenoids in children allergic (vasomotor) rhinitis seasonal or year-round, in the postoperative period acquisition costs surgery on the organs in the nasal cavity. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น